These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 37074676)
21. Reduced hip bone mineral density is associated with high levels of calciprotein particles in patients with Fabry disease. Bruell S; Nicholls KM; Hewitson TD; Talbot AS; Holt SG; Smith ER; Ruderman I Osteoporos Int; 2022 Aug; 33(8):1783-1794. PubMed ID: 35575807 [TBL] [Abstract][Full Text] [Related]
22. Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD. Smith ER; Ford ML; Tomlinson LA; Rajkumar C; McMahon LP; Holt SG Nephrol Dial Transplant; 2012 May; 27(5):1957-66. PubMed ID: 22105144 [TBL] [Abstract][Full Text] [Related]
23. Calciprotein particle inhibition explains magnesium-mediated protection against vascular calcification. Ter Braake AD; Eelderink C; Zeper LW; Pasch A; Bakker SJL; de Borst MH; Hoenderop JGJ; de Baaij JHF Nephrol Dial Transplant; 2020 May; 35(5):765-773. PubMed ID: 31605492 [TBL] [Abstract][Full Text] [Related]
24. Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-α. Aghagolzadeh P; Bachtler M; Bijarnia R; Jackson C; Smith ER; Odermatt A; Radpour R; Pasch A Atherosclerosis; 2016 Aug; 251():404-414. PubMed ID: 27289275 [TBL] [Abstract][Full Text] [Related]
25. Effect of nutritional calcium and phosphate loading on calciprotein particle kinetics in adults with normal and impaired kidney function. Tiong MK; Cai MMX; Toussaint ND; Tan SJ; Pasch A; Smith ER Sci Rep; 2022 May; 12(1):7358. PubMed ID: 35513558 [TBL] [Abstract][Full Text] [Related]
26. Recent Advances in the Management of Vascular Calcification in Patients with End-Stage Renal Disease. Nitta K; Ogawa T; Hanafusa N; Tsuchiya K Contrib Nephrol; 2019; 198():62-72. PubMed ID: 30991406 [TBL] [Abstract][Full Text] [Related]
27. Serum Calciprotein Monomers and Chronic Kidney Disease Progression. Tiong MK; Holt SG; Ford ML; Smith ER Am J Nephrol; 2022; 53(11-12):806-815. PubMed ID: 36473431 [TBL] [Abstract][Full Text] [Related]
28. Live Imaging of Calciprotein Particle Clearance and Receptor Mediated Uptake: Role of Calciprotein Monomers. Koeppert S; Ghallab A; Peglow S; Winkler CF; Graeber S; Büscher A; Hengstler JG; Jahnen-Dechent W Front Cell Dev Biol; 2021; 9():633925. PubMed ID: 33996793 [TBL] [Abstract][Full Text] [Related]
29. [New Developments in CKD-MBD. Why is phosphate overload harmful?]. Kuroo M Clin Calcium; 2014 Dec; 24(12):1785-92. PubMed ID: 25423923 [TBL] [Abstract][Full Text] [Related]
30. Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cells. Thiem U; Hewitson TD; Toussaint ND; Holt SG; Haller MC; Pasch A; Cejka D; Smith ER Nephrol Dial Transplant; 2023 May; 38(5):1282-1296. PubMed ID: 36107466 [TBL] [Abstract][Full Text] [Related]
31. Fetuin-A function in systemic mineral metabolism. Herrmann M; Kinkeldey A; Jahnen-Dechent W Trends Cardiovasc Med; 2012 Nov; 22(8):197-201. PubMed ID: 22902178 [TBL] [Abstract][Full Text] [Related]
32. Associations of Serum Calciprotein Particle Size and Transformation Time With Arterial Calcification, Arterial Stiffness, and Mortality in Incident Hemodialysis Patients. Chen W; Fitzpatrick J; Monroy-Trujillo JM; Sozio SM; Jaar BG; Estrella MM; Serrano J; Anokhina V; Miller BL; Melamed ML; Bushinsky DA; Parekh RS Am J Kidney Dis; 2021 Mar; 77(3):346-354. PubMed ID: 32800846 [TBL] [Abstract][Full Text] [Related]
34. Fetuin-A-containing calciprotein particles in mineral trafficking and vascular disease. Holt SG; Smith ER Nephrol Dial Transplant; 2016 Oct; 31(10):1583-7. PubMed ID: 27190332 [TBL] [Abstract][Full Text] [Related]
35. Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism. Kuro-o M Nat Rev Nephrol; 2013 Nov; 9(11):650-60. PubMed ID: 23774819 [TBL] [Abstract][Full Text] [Related]
36. Role of Chronic Kidney Disease (CKD)-Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD. Yamada S; Nakano T J Atheroscler Thromb; 2023 Aug; 30(8):835-850. PubMed ID: 37258233 [TBL] [Abstract][Full Text] [Related]
37. Calciprotein particle (CPP): a true culprit of phosphorus woes? Kuro-o M Nefrologia; 2014; 34(1):1-4. PubMed ID: 24336683 [No Abstract] [Full Text] [Related]
38. Lumenal calcification and microvasculopathy in fetuin-A-deficient mice lead to multiple organ morbidity. Herrmann M; Babler A; Moshkova I; Gremse F; Kiessling F; Kusebauch U; Nelea V; Kramann R; Moritz RL; McKee MD; Jahnen-Dechent W PLoS One; 2020; 15(2):e0228503. PubMed ID: 32074120 [TBL] [Abstract][Full Text] [Related]
39. Serum fetuin-A concentration and fetuin-A-containing calciprotein particles in patients with chronic inflammatory disease and renal failure. Smith ER; Cai MM; McMahon LP; Pedagogos E; Toussaint ND; Brumby C; Holt SG Nephrology (Carlton); 2013 Mar; 18(3):215-21. PubMed ID: 23231493 [TBL] [Abstract][Full Text] [Related]
40. A study on biorelevant calciprotein particles: Effect of stabilizing agents on the formation and crystallization mechanisms. Gelli R; Pucci V; Ridi F; Baglioni P J Colloid Interface Sci; 2022 Aug; 620():431-441. PubMed ID: 35439694 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]